Regno Unito - inglese - MHRA (Medicines & Healthcare Products Regulatory Agency)

bayer plc - sodium alginate; calcium carbonate; sodium bicarbonate - oral suspension - 50mg/1ml ; 16mg/1ml ; 26.7mg/1ml

Malesia - inglese - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

hovid berhad - sodium alginate; ssodium bicarbonate__; calcium carbonate -

Malesia - inglese - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

hovid berhad - sodium alginate; sodium bicarbonate; calcium carbonate -

Regno Unito - inglese - MHRA (Medicines & Healthcare Products Regulatory Agency)

reckitt benckiser healthcare (uk) ltd - sodium alginate; sodium bicarbonate; calcium carbonate - chewable tablet - 250mg ; 106.5mg ; 187.5mg

Kenya - inglese - Pharmacy and Poisons Board

eastleigh pharmaceuticals co. ltd p.o box 167-00610 nairobi, kenya - sodium alginate, sodium bicarbonate & calcium… - oral suspension - each 5 ml solution contains: sodium alginate… - alginic acid

Malta - inglese - Malta Medicines Authority

reckitt benckiser healthcare (uk) limited 103-105 bath road slough sl1 3uh, united kingdom - calcium carbonate, sodium alginate, sodium hydrogen - oral suspension - sodium alginate 250 mg/5ml sodium hydrogen carbonate 133.5 mg/5ml calcium carbonate 80 mg/5ml - drugs for acid related disorders

Malta - inglese - Malta Medicines Authority

reckitt benckiser healthcare (uk) limited 103-105 bath road slough sl1 3uh, united kingdom - calcium carbonate, sodium alginate, sodium hydrogen - chewable tablet - sodium alginate 250 mg calcium carbonate 80 mg sodium hydrogen carbonate 133.5 mg - drugs for acid related disorders

Stati Uniti - inglese - NLM (National Library of Medicine)

golden state medical supply, inc. - diclofenac sodium (unii: qtg126297q) (diclofenac - unii:144o8ql0l1) - diclofenac sodium 50 mg - carefully consider the potential benefits and risks of diclofenac sodium delayed-release tablets and other treatment options before deciding to use diclofenac sodium delayed-release tablets. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings; gastrointestinal bleeding, ulceration, and perforation) . diclofenac sodium delayed-release tablets are indicated: - for relief of the signs and symptoms of osteoarthritis - for relief of the signs and symptoms of rheumatoid arthritis - for acute or long-term use in the relief of signs and symptoms of ankylosing spondylitis diclofenac sodium delayed-release tablets are contraindicated in the following patients: - known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to diclofenac or any components of the drug product (see warnings; anaphylactic reactions, serious skin reactions)

Stati Uniti - inglese - NLM (National Library of Medicine)

mckesson corporation dba sky packaging - diclofenac sodium (unii: qtg126297q) (diclofenac - unii:144o8ql0l1) - diclofenac sodium 75 mg - carefully consider the potential benefits and risks of diclofenac sodium delayed-release tablets and other treatment options before deciding to use diclofenac sodium delayed-release tablets. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings; gastrointestinal bleeding, ulceration, and perforation) . diclofenac sodium delayed-release tablets, usp are indicated: - for relief of the signs and symptoms of osteoarthritis - for relief of the signs and symptoms of rheumatoid arthritis - for acute or long-term use in the relief of signs and symptoms of ankylosing spondylitis diclofenac sodium delayed-release tablets are contraindicated in the following patients: - known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to diclofenac or any components of the drug product (see warnings; anaphylactic reactions, serious skin reactions) . - history of asthma, urticaria, or other allergic-type reactions after taking aspirin or ot

Stati Uniti - inglese - NLM (National Library of Medicine)

ncs healthcare of ky, inc dba vangard labs - diclofenac sodium (unii: qtg126297q) (diclofenac - unii:144o8ql0l1) - diclofenac sodium 50 mg - carefully consider the potential benefits and risks of diclofenac sodium delayed-release and other treatment options before deciding to use diclofenac sodium delayed-release. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings). diclofenac sodium delayed-release tablets are indicated: • for relief of signs and symptoms of osteoarthritis • for relief of signs and symptoms of rheumatoid arthritis • for acute or long-term use in the relief of signs and symptoms of ankylosing spondylitis diclofenac sodium delayed-release tablets are contraindicated in patients with known hypersensitivity to diclofenac. diclofenac sodium delayed-release should not be given to patients who have experienced asthma, urticaria, or other allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see warnings, anaphylactoid reactions, and precautions, preexisting asthma)